About this Research Topic
The field of nuclear medicine has made significant strides in imaging the cellular microenvironment, which encompasses the immediate surroundings of a cell, including its physical, chemical, and biological components. This microenvironment plays a crucial role in both oncological and non-oncological diseases, influencing cellular behavior and functions. Understanding and distinguishing between pathological and healthy microenvironments is vital in the era of personalized medicine. Recent advancements have successfully targeted components such as FAP, VEGF, and PSMA for imaging and therapeutic purposes, heralding a new era of theragnostic approaches. Despite these advancements, there remains a need for further exploration of advanced imaging tools to better understand and visualize the pathological microenvironment through nuclear medicine.
This Research Topic aims to explore and enhance the understanding of the microenvironment in both oncological and non-oncological diseases through advanced imaging techniques in nuclear medicine. The primary objectives include developing new imaging tracers, conducting preclinical studies to establish animal models that reflect novel molecular pathological processes, and translating these findings into clinical applications. By addressing these objectives, the research seeks to improve diagnostic, therapeutic, and theragnostic strategies, ultimately enhancing patient management.
To gather further insights into the imaging of the microenvironment in oncological and non-oncological diseases, we welcome articles addressing, but not limited to, the following themes:
• Tracer development and new radiochemistry for imaging tools.
• Preclinical studies introducing feasible animal models to display novel molecular pathological processes.
• Translational studies from pre-clinical/in vitro to in vivo applications in diagnostic, therapeutic, and theragnostic fields.
• Clinical research studies on novel or existing radiopharmaceuticals targeting the microenvironment to improve patient management.
This Research Topic aims to explore and enhance the understanding of the microenvironment in both oncological and non-oncological diseases through advanced imaging techniques in nuclear medicine. The primary objectives include developing new imaging tracers, conducting preclinical studies to establish animal models that reflect novel molecular pathological processes, and translating these findings into clinical applications. By addressing these objectives, the research seeks to improve diagnostic, therapeutic, and theragnostic strategies, ultimately enhancing patient management.
To gather further insights into the imaging of the microenvironment in oncological and non-oncological diseases, we welcome articles addressing, but not limited to, the following themes:
• Tracer development and new radiochemistry for imaging tools.
• Preclinical studies introducing feasible animal models to display novel molecular pathological processes.
• Translational studies from pre-clinical/in vitro to in vivo applications in diagnostic, therapeutic, and theragnostic fields.
• Clinical research studies on novel or existing radiopharmaceuticals targeting the microenvironment to improve patient management.
Keywords: Imaging, Nuclear Medicine, Oncology, Microenvironment, Theragnostics, Radiopharmaceuticals
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
